Nebulized Lidocaine to Prevent Cough at Emergence From Anesthesia
NCT ID: NCT04000633
Last Updated: 2019-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2019-06-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Alkalinized Lidocaine in the Endotracheal Tube Cuff on the Incidence of Coughing During Emergence
NCT01715688
Inhalation of Lidocaine Before Intubation
NCT01838993
Comparing Efficacy Preoperative Nebulized: Ketamine , Mgspo4 ,and Lidocaine In Attenuating Endotracheal Sore Throat
NCT03729973
Comparison of Effectiveness Between the Combination of Lidocaine Sprayed at Laryngeal Inlet and on the Cuff of Endotracheal Tube Versus Intravenous Lidocaine for Reducing Cough During Extubation
NCT04090112
Interest of Lidocaine in Children with Upper Airway Infection Undergoing General Anesthesia
NCT06584461
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This randomized controlled study will compare the effect of Lidocaine and placebo nebulization in the immediate pre operative period in order to evaluate the effectiveness in reducing post extubation cough and sore throat.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lidocaine group
the patients of this group will recieve nebulization of 5 ml of 2% lidocaine prior to induction of general anesthesia
Lidocaine 2%
the patients of this group will recieve nebulization of 5 ml of 2% lidocaine prior to induction of general anesthesia
Placebo group
the patients of this group will recieve nebulization of 5 ml of normal saline prior to induction of general anesthesia
Normal saline
Normal saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaine 2%
the patients of this group will recieve nebulization of 5 ml of 2% lidocaine prior to induction of general anesthesia
Normal saline
Normal saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA status I or II
Exclusion Criteria
* Surgery\>3 hours
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mongi Slim Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mhamed Sami Mebazaa
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mhamed Sami Mebazaa, Professor
Role: PRINCIPAL_INVESTIGATOR
Mongi Slim Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mongi Slim Hospital
La Marsa, Tunis Governorate, Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
lidocaïne cough prevention
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.